Theranostic anti-SSTR2 CAR T-cell Therapy for Neuroendocrine Tumors
Carolin Kitzberger, PhD
Funded Research Projects
Developing next-generation TCR-based therapies for pancreatic neuroendocrine tumors
Mauro Cives, MD
Novel Method to Assess NET Metabolism and Somatostatin Receptor Expression in a Single PET scan
Craig Levin, PhD
Role of YAP and TAZ restriction in Merkel Cell Carcinoma development
Chiara Mazziotta, PhD
Define the mechanisms and the impact of potential critical somatic gene mutations in DIPNECH
Hui Yu, MD, PhD
Uncovering metaplastic transitions to improve classification of pancreatic neuroendocrine neoplasms (PanNENs)
Kirsten Kübler, MD, PhD
Targeted delivery of DNA repair-inhibiting drugs to GEP-NETs
Susanne Kossatz, PhD
Elucidating the role of aging in GEP-NET development
Suzann Duan, PhD
PRMT5 inhibitor: next option for neuroendocrine tumors?
Thomas Walter, MD, PhD
Investigating GLP-1 receptor as a novel prognostic and therapeutic biomarker for pancreas NETs
Tiane Chen, MD, PhD, MSc